Biomonitoring

For over 25 years, ERG has helped government agencies plan and implement biomonitoring programs across the nation to measure biomarkers of exposure in blood, urine, and other human tissue. These measurements help public health officials better understand the extent of individual and community exposures to chemicals in the local environment and guide their public health decisions. Results of ERG’s biomonitoring work have helped our clients learn whether community exposure levels are higher than expected or above health-based thresholds; what exposure reduction interventions or further study may be needed; and whether additional testing or clinical monitoring would be helpful. ERG biomonitoring experts (who are all certified in ethical human subject research and protecting participant rights and privacy) have supported large-scale exposure assessments, health studies, and surveillance programs, including assessments of emerging contaminants (e.g., PFAS) and legacy chemicals (e.g., metals, PCBs). Our team offers a comprehensive suite of services, including goal setting; protocol development; community engagement and recruitment; data collection and analysis; and communicating results back to the community. Whatever the project’s scope, scale, or location, we handle all scientific and logistical details to ensure our client’s program objectives are met.